nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketamine—ABCB1—adrenal gland cancer	0.758	1	CbGaD
Ketamine—SLC6A2—sympathetic nervous system—adrenal gland cancer	0.00201	0.264	CbGeAlD
Ketamine—GRIN2C—adrenal cortex—adrenal gland cancer	0.00095	0.124	CbGeAlD
Ketamine—CYP2C9—urine—adrenal gland cancer	0.000804	0.105	CbGeAlD
Ketamine—CYP3A4—urine—adrenal gland cancer	0.000613	0.0804	CbGeAlD
Ketamine—TACR1—adrenal gland—adrenal gland cancer	0.00052	0.0681	CbGeAlD
Ketamine—GRIN2A—adrenal gland—adrenal gland cancer	0.000474	0.0621	CbGeAlD
Ketamine—SLC6A2—gonad—adrenal gland cancer	0.000242	0.0317	CbGeAlD
Ketamine—CYP2B6—adrenal cortex—adrenal gland cancer	0.000215	0.0282	CbGeAlD
Ketamine—DRD2—pituitary gland—adrenal gland cancer	0.000215	0.0282	CbGeAlD
Ketamine—SLC6A2—adrenal gland—adrenal gland cancer	0.000211	0.0276	CbGeAlD
Ketamine—OPRD1—Signaling Pathways—GNRHR—adrenal gland cancer	0.000208	0.000885	CbGpPWpGaD
Ketamine—OPRK1—G alpha (i) signalling events—POMC—adrenal gland cancer	0.000207	0.000884	CbGpPWpGaD
Ketamine—OPRD1—GPCR downstream signaling—TSHR—adrenal gland cancer	0.000207	0.000881	CbGpPWpGaD
Ketamine—DRD2—GPCR ligand binding—TSHR—adrenal gland cancer	0.000205	0.000875	CbGpPWpGaD
Ketamine—OPRK1—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.000203	0.000867	CbGpPWpGaD
Ketamine—TACR1—Signaling by GPCR—CDC42—adrenal gland cancer	0.000203	0.000865	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—TOP2A—adrenal gland cancer	0.000202	0.000861	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—SPRY2—adrenal gland cancer	0.000202	0.000861	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—GNRHR—adrenal gland cancer	0.000197	0.000841	CbGpPWpGaD
Ketamine—DRD2—G alpha (i) signalling events—GNAS—adrenal gland cancer	0.000197	0.000841	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—TSHR—adrenal gland cancer	0.000197	0.000839	CbGpPWpGaD
Ketamine—CYP2C8—pituitary gland—adrenal gland cancer	0.000194	0.0254	CbGeAlD
Ketamine—TACR1—Signaling by GPCR—GNAS—adrenal gland cancer	0.000194	0.000826	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.000193	0.000823	CbGpPWpGaD
Ketamine—OPRD1—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.000188	0.000802	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—TSHR—adrenal gland cancer	0.000188	0.0008	CbGpPWpGaD
Ketamine—PTGS1—Biological oxidations—POMC—adrenal gland cancer	0.000188	0.0008	CbGpPWpGaD
Ketamine—OPRK1—GPCR ligand binding—GNAS—adrenal gland cancer	0.000187	0.000795	CbGpPWpGaD
Ketamine—CYP2C9—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.000186	0.000791	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—MEN1—adrenal gland cancer	0.000185	0.000789	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—GNRH1—adrenal gland cancer	0.000185	0.000787	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—GNRHR—adrenal gland cancer	0.000182	0.000776	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—ZNRF3—adrenal gland cancer	0.000181	0.000774	CbGpPWpGaD
Ketamine—OPRK1—GPCR downstream signaling—TSHR—adrenal gland cancer	0.000181	0.000772	CbGpPWpGaD
Ketamine—PTGS1—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.000181	0.000771	CbGpPWpGaD
Ketamine—CYP2B6—gonad—adrenal gland cancer	0.000178	0.0234	CbGeAlD
Ketamine—OPRM1—G alpha (i) signalling events—POMC—adrenal gland cancer	0.000175	0.000747	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.000172	0.000732	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.000169	0.000721	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—SDHB—adrenal gland cancer	0.000168	0.000715	CbGpPWpGaD
Ketamine—OPRK1—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.000165	0.000703	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—TSHR—adrenal gland cancer	0.000165	0.000701	CbGpPWpGaD
Ketamine—PTGS1—cardiac atrium—adrenal gland cancer	0.000161	0.0211	CbGeAlD
Ketamine—SLC6A2—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.00016	0.000684	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—ZNRF3—adrenal gland cancer	0.000159	0.000678	CbGpPWpGaD
Ketamine—OPRM1—GPCR ligand binding—GNAS—adrenal gland cancer	0.000158	0.000672	CbGpPWpGaD
Ketamine—PTGS1—pituitary gland—adrenal gland cancer	0.000157	0.0206	CbGeAlD
Ketamine—OPRM1—Signaling by GPCR—GNRH1—adrenal gland cancer	0.000156	0.000665	CbGpPWpGaD
Ketamine—CYP2B6—adrenal gland—adrenal gland cancer	0.000155	0.0204	CbGeAlD
Ketamine—OPRM1—Signaling Pathways—GNRHR—adrenal gland cancer	0.000154	0.000656	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—TSHR—adrenal gland cancer	0.000153	0.000653	CbGpPWpGaD
Ketamine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.000151	0.000644	CbGpPWpGaD
Ketamine—TACR1—GPCR downstream signaling—POMC—adrenal gland cancer	0.000144	0.000613	CbGpPWpGaD
Ketamine—OPRD1—GPCR ligand binding—POMC—adrenal gland cancer	0.000143	0.000611	CbGpPWpGaD
Ketamine—CYP2B6—Biological oxidations—POMC—adrenal gland cancer	0.000143	0.00061	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.000143	0.00061	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—PRKACA—adrenal gland cancer	0.000141	0.000602	CbGpPWpGaD
Ketamine—PTGS1—adrenal gland—adrenal gland cancer	0.00014	0.0184	CbGeAlD
Ketamine—OPRM1—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.000139	0.000594	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—TSHR—adrenal gland cancer	0.000139	0.000593	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—PRKACA—adrenal gland cancer	0.000135	0.000574	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—ZNRF3—adrenal gland cancer	0.000135	0.000573	CbGpPWpGaD
Ketamine—DRD2—G alpha (i) signalling events—POMC—adrenal gland cancer	0.000133	0.000566	CbGpPWpGaD
Ketamine—PTGS1—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.000132	0.000563	CbGpPWpGaD
Ketamine—TACR1—Signaling by GPCR—POMC—adrenal gland cancer	0.000131	0.000556	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00013	0.000555	CbGpPWpGaD
Ketamine—SLC6A2—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.00013	0.000554	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—SDHB—adrenal gland cancer	0.000128	0.000545	CbGpPWpGaD
Ketamine—SLC6A2—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.000128	0.000544	CbGpPWpGaD
Ketamine—GRIN1—Axon guidance—EGFR—adrenal gland cancer	0.000127	0.00054	CbGpPWpGaD
Ketamine—OPRD1—GPCR downstream signaling—CDC42—adrenal gland cancer	0.000126	0.000536	CbGpPWpGaD
Ketamine—OPRK1—GPCR ligand binding—POMC—adrenal gland cancer	0.000126	0.000535	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—GNRH1—adrenal gland cancer	0.000124	0.00053	CbGpPWpGaD
Ketamine—GRIN2B—Axon guidance—EGFR—adrenal gland cancer	0.000123	0.000526	CbGpPWpGaD
Ketamine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.000122	0.000522	CbGpPWpGaD
Ketamine—CYP2C8—Biological oxidations—POMC—adrenal gland cancer	0.000121	0.000517	CbGpPWpGaD
Ketamine—OPRD1—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00012	0.000512	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—CDC42—adrenal gland cancer	0.00012	0.000511	CbGpPWpGaD
Ketamine—DRD2—GPCR ligand binding—GNAS—adrenal gland cancer	0.000119	0.000509	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—GNRH1—adrenal gland cancer	0.000118	0.000504	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—PRKACA—adrenal gland cancer	0.000118	0.000503	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.000117	0.000498	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—GNRHR—adrenal gland cancer	0.000117	0.000497	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—TSHR—adrenal gland cancer	0.000116	0.000495	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—IGF2—adrenal gland cancer	0.000116	0.000492	CbGpPWpGaD
Ketamine—ABCB1—adrenal cortex—adrenal gland cancer	0.000115	0.0151	CbGeAlD
Ketamine—TACR1—Signaling Pathways—GNAS—adrenal gland cancer	0.000115	0.000488	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—CDC42—adrenal gland cancer	0.000114	0.000487	CbGpPWpGaD
Ketamine—GRIN1—Developmental Biology—CTNNB1—adrenal gland cancer	0.000114	0.000486	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—SPRY2—adrenal gland cancer	0.000114	0.000485	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—IGF1R—adrenal gland cancer	0.000112	0.000476	CbGpPWpGaD
Ketamine—GRIN2B—Developmental Biology—CTNNB1—adrenal gland cancer	0.000111	0.000474	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—TSHR—adrenal gland cancer	0.000111	0.000473	CbGpPWpGaD
Ketamine—OPRK1—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00011	0.00047	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—GNAS—adrenal gland cancer	0.000109	0.000465	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—GNRH1—adrenal gland cancer	0.000109	0.000465	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.000108	0.000462	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—SDHB—adrenal gland cancer	0.000108	0.000462	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—SDHD—adrenal gland cancer	0.000108	0.000461	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—RRM1—adrenal gland cancer	0.000108	0.000461	CbGpPWpGaD
Ketamine—OPRM1—GPCR ligand binding—POMC—adrenal gland cancer	0.000106	0.000452	CbGpPWpGaD
Ketamine—DRD2—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.000106	0.00045	CbGpPWpGaD
Ketamine—OPRK1—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000105	0.000449	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—TSHR—adrenal gland cancer	0.000105	0.000449	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—adrenal gland cancer	0.000105	0.000449	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—MEN1—adrenal gland cancer	0.000104	0.000444	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—ZNRF3—adrenal gland cancer	0.000102	0.000434	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—CDC42—adrenal gland cancer	0.0001	0.000427	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—PRKACA—adrenal gland cancer	9.98e-05	0.000425	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—SPRY2—adrenal gland cancer	9.98e-05	0.000425	CbGpPWpGaD
Ketamine—CYP2C9—Biological oxidations—POMC—adrenal gland cancer	9.86e-05	0.00042	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—TSHR—adrenal gland cancer	9.72e-05	0.000414	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—TERT—adrenal gland cancer	9.61e-05	0.00041	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—GNAS—adrenal gland cancer	9.57e-05	0.000408	CbGpPWpGaD
Ketamine—ABCB1—gonad—adrenal gland cancer	9.53e-05	0.0125	CbGeAlD
Ketamine—CYP2C9—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	9.51e-05	0.000405	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—SDHB—adrenal gland cancer	9.44e-05	0.000402	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—CDC42—adrenal gland cancer	9.32e-05	0.000397	CbGpPWpGaD
Ketamine—ABCB1—pituitary gland—adrenal gland cancer	9.29e-05	0.0122	CbGeAlD
Ketamine—OPRM1—Signaling Pathways—GNRH1—adrenal gland cancer	9.22e-05	0.000393	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—MEN1—adrenal gland cancer	9.14e-05	0.00039	CbGpPWpGaD
Ketamine—GRIN1—Developmental Biology—EGFR—adrenal gland cancer	9.04e-05	0.000385	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—GNAS—adrenal gland cancer	8.91e-05	0.00038	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—SDHB—adrenal gland cancer	8.82e-05	0.000376	CbGpPWpGaD
Ketamine—GRIN2B—Developmental Biology—EGFR—adrenal gland cancer	8.81e-05	0.000375	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	8.53e-05	0.000363	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—CDC42—adrenal gland cancer	8.47e-05	0.000361	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—SPRY2—adrenal gland cancer	8.43e-05	0.000359	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—BAD—adrenal gland cancer	8.36e-05	0.000356	CbGpPWpGaD
Ketamine—ABCB1—adrenal gland—adrenal gland cancer	8.3e-05	0.0109	CbGeAlD
Ketamine—CYP2B6—Metabolism—SDHD—adrenal gland cancer	8.25e-05	0.000352	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—RRM1—adrenal gland cancer	8.25e-05	0.000352	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—TSHR—adrenal gland cancer	8.22e-05	0.00035	CbGpPWpGaD
Ketamine—OPRD1—GPCR downstream signaling—POMC—adrenal gland cancer	8.09e-05	0.000345	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—GNAS—adrenal gland cancer	8.09e-05	0.000345	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—MED12—adrenal gland cancer	8.06e-05	0.000343	CbGpPWpGaD
Ketamine—DRD2—GPCR ligand binding—POMC—adrenal gland cancer	8.04e-05	0.000343	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—PRKACA—adrenal gland cancer	7.96e-05	0.000339	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—adrenal gland cancer	7.74e-05	0.00033	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—MEN1—adrenal gland cancer	7.73e-05	0.000329	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—POMC—adrenal gland cancer	7.71e-05	0.000329	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—BRAF—adrenal gland cancer	7.61e-05	0.000324	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—PRKACA—adrenal gland cancer	7.57e-05	0.000322	CbGpPWpGaD
Ketamine—TACR1—Signaling by GPCR—EGFR—adrenal gland cancer	7.38e-05	0.000315	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—POMC—adrenal gland cancer	7.35e-05	0.000313	CbGpPWpGaD
Ketamine—PTGS1—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	7.2e-05	0.000307	CbGpPWpGaD
Ketamine—DRD2—Circadian rythm related genes—TP53—adrenal gland cancer	7.15e-05	0.000305	CbGpPWpGaD
Ketamine—OPRK1—GPCR downstream signaling—POMC—adrenal gland cancer	7.1e-05	0.000303	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—CDC42—adrenal gland cancer	7.07e-05	0.000301	CbGpPWpGaD
Ketamine—ABCB1—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	7.06e-05	0.000301	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—GNRH1—adrenal gland cancer	6.99e-05	0.000298	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—RRM1—adrenal gland cancer	6.98e-05	0.000298	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—SDHD—adrenal gland cancer	6.98e-05	0.000298	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—PRKACA—adrenal gland cancer	6.98e-05	0.000297	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	6.94e-05	0.000296	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—adrenal gland cancer	6.93e-05	0.000295	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—GNAS—adrenal gland cancer	6.75e-05	0.000288	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—CDC42—adrenal gland cancer	6.75e-05	0.000288	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—IGF2—adrenal gland cancer	6.51e-05	0.000277	CbGpPWpGaD
Ketamine—CYP3A4—Biological oxidations—POMC—adrenal gland cancer	6.5e-05	0.000277	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—GNAS—adrenal gland cancer	6.45e-05	0.000275	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—POMC—adrenal gland cancer	6.45e-05	0.000275	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—CDC42—adrenal gland cancer	6.42e-05	0.000274	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—SPRY2—adrenal gland cancer	6.39e-05	0.000272	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—IGF1R—adrenal gland cancer	6.29e-05	0.000268	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—TSHR—adrenal gland cancer	6.23e-05	0.000265	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—MED12—adrenal gland cancer	6.15e-05	0.000262	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—GNAS—adrenal gland cancer	6.13e-05	0.000261	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—RRM1—adrenal gland cancer	6.08e-05	0.000259	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—SDHD—adrenal gland cancer	6.08e-05	0.000259	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—POMC—adrenal gland cancer	6e-05	0.000256	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—CDC42—adrenal gland cancer	5.92e-05	0.000252	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—PRKACA—adrenal gland cancer	5.9e-05	0.000251	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—PRKACA—adrenal gland cancer	5.88e-05	0.000251	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—MEN1—adrenal gland cancer	5.85e-05	0.00025	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—SDHB—adrenal gland cancer	5.82e-05	0.000248	CbGpPWpGaD
Ketamine—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	5.75e-05	0.000245	CbGpPWpGaD
Ketamine—ABCB1—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	5.73e-05	0.000244	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—IGF2—adrenal gland cancer	5.7e-05	0.000243	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—RRM1—adrenal gland cancer	5.68e-05	0.000242	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—SDHD—adrenal gland cancer	5.68e-05	0.000242	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—GNAS—adrenal gland cancer	5.66e-05	0.000241	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—IGF1R—adrenal gland cancer	5.52e-05	0.000235	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—CTNNB1—adrenal gland cancer	5.5e-05	0.000235	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—adrenal gland cancer	5.49e-05	0.000234	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—POMC—adrenal gland cancer	5.45e-05	0.000232	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—TERT—adrenal gland cancer	5.41e-05	0.000231	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—MED12—adrenal gland cancer	5.21e-05	0.000222	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—CDC42—adrenal gland cancer	5e-05	0.000213	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—IGF2—adrenal gland cancer	4.82e-05	0.000205	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—GNAS—adrenal gland cancer	4.78e-05	0.000204	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—GNAS—adrenal gland cancer	4.77e-05	0.000203	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—TERT—adrenal gland cancer	4.75e-05	0.000202	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—BAD—adrenal gland cancer	4.71e-05	0.000201	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—ABCB1—adrenal gland cancer	4.68e-05	0.000199	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—IGF1R—adrenal gland cancer	4.66e-05	0.000199	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	4.65e-05	0.000198	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	4.61e-05	0.000196	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—POMC—adrenal gland cancer	4.55e-05	0.000194	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—MED12—adrenal gland cancer	4.54e-05	0.000193	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—PRKACA—adrenal gland cancer	4.49e-05	0.000191	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—PRKACA—adrenal gland cancer	4.47e-05	0.00019	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—EGFR—adrenal gland cancer	4.36e-05	0.000186	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—POMC—adrenal gland cancer	4.34e-05	0.000185	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—BRAF—adrenal gland cancer	4.29e-05	0.000183	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—MED12—adrenal gland cancer	4.24e-05	0.000181	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—EGFR—adrenal gland cancer	4.16e-05	0.000177	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—BAD—adrenal gland cancer	4.13e-05	0.000176	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—POMC—adrenal gland cancer	4.13e-05	0.000176	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—TERT—adrenal gland cancer	4.01e-05	0.000171	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—POMC—adrenal gland cancer	3.81e-05	0.000162	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—PRKACA—adrenal gland cancer	3.8e-05	0.000162	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CDC42—adrenal gland cancer	3.79e-05	0.000162	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	3.79e-05	0.000161	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—BRAF—adrenal gland cancer	3.76e-05	0.00016	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—RRM1—adrenal gland cancer	3.75e-05	0.00016	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—SDHD—adrenal gland cancer	3.75e-05	0.00016	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	3.71e-05	0.000158	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—TP53—adrenal gland cancer	3.66e-05	0.000156	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—IGF2—adrenal gland cancer	3.65e-05	0.000156	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—EGFR—adrenal gland cancer	3.64e-05	0.000155	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—GNAS—adrenal gland cancer	3.64e-05	0.000155	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—GNAS—adrenal gland cancer	3.62e-05	0.000154	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—ABCB1—adrenal gland cancer	3.57e-05	0.000152	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—IGF1R—adrenal gland cancer	3.53e-05	0.000151	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—BAD—adrenal gland cancer	3.49e-05	0.000149	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—PRKACA—adrenal gland cancer	3.31e-05	0.000141	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—POMC—adrenal gland cancer	3.22e-05	0.000137	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—POMC—adrenal gland cancer	3.21e-05	0.000137	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—BRAF—adrenal gland cancer	3.18e-05	0.000135	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—CTNNB1—adrenal gland cancer	3.1e-05	0.000132	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—PRKACA—adrenal gland cancer	3.09e-05	0.000132	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—EGFR—adrenal gland cancer	3.08e-05	0.000131	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—GNAS—adrenal gland cancer	3.08e-05	0.000131	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—TERT—adrenal gland cancer	3.04e-05	0.00013	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	3.02e-05	0.000129	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—ABCB1—adrenal gland cancer	3.02e-05	0.000129	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—MED12—adrenal gland cancer	2.79e-05	0.000119	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—CTNNB1—adrenal gland cancer	2.72e-05	0.000116	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—GNAS—adrenal gland cancer	2.68e-05	0.000114	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—BAD—adrenal gland cancer	2.65e-05	0.000113	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—PTGS2—adrenal gland cancer	2.56e-05	0.000109	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—GNAS—adrenal gland cancer	2.5e-05	0.000107	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—ABCB1—adrenal gland cancer	2.46e-05	0.000105	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—EGFR—adrenal gland cancer	2.46e-05	0.000105	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—POMC—adrenal gland cancer	2.45e-05	0.000104	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—POMC—adrenal gland cancer	2.44e-05	0.000104	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—BRAF—adrenal gland cancer	2.41e-05	0.000103	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—EGFR—adrenal gland cancer	2.33e-05	9.95e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—CTNNB1—adrenal gland cancer	2.3e-05	9.79e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—EGFR—adrenal gland cancer	2.15e-05	9.18e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—POMC—adrenal gland cancer	2.07e-05	8.83e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—TP53—adrenal gland cancer	2.06e-05	8.79e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—PRKACA—adrenal gland cancer	2.04e-05	8.69e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—PTGS2—adrenal gland cancer	1.95e-05	8.32e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—EGFR—adrenal gland cancer	1.82e-05	7.76e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—TP53—adrenal gland cancer	1.81e-05	7.7e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—POMC—adrenal gland cancer	1.81e-05	7.7e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CTNNB1—adrenal gland cancer	1.74e-05	7.42e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—POMC—adrenal gland cancer	1.69e-05	7.19e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—PTGS2—adrenal gland cancer	1.65e-05	7.05e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—GNAS—adrenal gland cancer	1.65e-05	7.04e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—ABCB1—adrenal gland cancer	1.62e-05	6.91e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—TP53—adrenal gland cancer	1.53e-05	6.51e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—PTGS2—adrenal gland cancer	1.44e-05	6.14e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—EGFR—adrenal gland cancer	1.38e-05	5.88e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—PTGS2—adrenal gland cancer	1.35e-05	5.73e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—TP53—adrenal gland cancer	1.16e-05	4.93e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—POMC—adrenal gland cancer	1.11e-05	4.74e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—PTGS2—adrenal gland cancer	8.87e-06	3.78e-05	CbGpPWpGaD
